Skip to content

Occlusin Light Cured Visible Radiopaque Composite

by Coe Laboratories, Inc.

510(k) K844326

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK844326 Date3 Dec 1984ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
EBF
Device Class
Class II
Regulation
21 CFR Part 872.3690
Advisory Committee
Dental
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Occlusin Light Cured Visible Radiopaque Composite is a dental composite material designed for restorative applications in dentistry. Classified under product code EBF, it is a radiopaque, light-activated composite intended for use in dental fillings and restorations, providing visibility under X-ray imaging for diagnostic purposes.

This composite is supplied as a single-use dental material and requires light curing to harden in place. It is regulated under FDA 510(k) clearance (K844326) and falls under the Dental advisory committee classification. The device is intended for use in clinical settings by dental professionals, adhering to standard dental restoration protocols. No additional sterility or reusable specifications are noted in the regulatory data.

Other devices from Coe Laboratories, Inc.

See all devices from Coe Laboratories, Inc. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Occlusin Light-Cured Visible Radiopaque Composite used for?

    This composite is specifically designed for dental restorative applications, such as fillings and repairs. Its radiopaque properties allow visibility under X-ray imaging, which is critical for diagnosing and monitoring the placement and integrity of dental restorations over time. The light-curing feature ensures proper hardening in the mouth, adhering to standard dental restoration protocols.

  • How is the Occlusin Light-Cured Visible Radiopaque Composite supplied?

    The Occlusin Light-Cured Visible Radiopaque Composite is supplied as a single-use dental material. This means each application requires a new unit, ensuring sterility and reducing the risk of cross-contamination in clinical settings. The material is intended for professional use only by dental practitioners.

  • Is sterility a concern with this composite?

    No additional sterility specifications are noted for this composite beyond its single-use design. Since it is intended for one-time clinical use, the manufacturer ensures it meets regulatory standards for dental materials without requiring further sterilization procedures by the user. Always follow manufacturer guidelines for handling and application.

  • Can this composite be reused?

    No, this composite is explicitly designed for single-use only. Reusing dental composites can compromise patient safety by introducing contamination risks or altering the material’s properties. The radiopaque and light-cured features are optimized for one application, ensuring reliable performance and diagnostic visibility.

  • What regulatory approval does the Occlusin Light-Cured Visible Radiopaque Composite hold?

    The Occlusin Light-Cured Visible Radiopaque Composite holds FDA 510(k) clearance under the classification of Dental (product code EBF). This clearance indicates that the device has been deemed substantially equivalent to a legally marketed predicate device, meeting regulatory standards for safety and effectiveness in dental restorative applications.